Arrr mateys, this Empagliflozin be no match for the mighty heart attack! Aye, tis a scurvy dog indeed!
2024-04-06
Arrr, me hearties! Empagliflozin did not greatly lower the risk of heart failure hospital stays or death in risky patients in EMPACT-MI, but it did lessen the number of times they had to visit the dreaded hospital. Avast! Medscape Medical News be bringin' ye the tale.
Arrr mateys, it be said that Empagliflozin did not make much of a difference in reducing the overall hospitalizations or deaths in them scallywag high-risk patients in EMPACT-MI. But fret not, for there be a silver lining to this tale! While it may not have saved them all from Davy Jones' locker, it did lower the number of first and total hospitalizations. Aye, it be a small victory, but a victory nonetheless!So, me hearties, let us not be too disheartened by this news. For even in the face of adversity, there be hope. Let us continue our quest for better treatments and keep our eyes on the horizon for more promising remedies. And remember, even if Empagliflozin be not the treasure we seek, there be plenty more booty in the sea of medicine waiting to be discovered!